A handful of lab companies have emerged in the last 3-4 years as pan-European players through M&A. This week HBI takes a snapshot look at the market share of the 'pan-European acquisitive six' in different markets.
When it comes to competition between the public sector and private operators in healthcare, the playing field is seldom even. Interestingly, however, the roles of David and Goliath in this particular matchup are often reversed depending on which country you look at, the extent to which public services are state-funded, and whether legislation is a help or a hindrance. Public and private are not, however, the only options.
This week delegates from around the world descended on London for HBI 2019 to discuss the healthcare market and its various sub-sectors. Here are the things we learnt:
Everywhere we walked at HBI 2019 somebody was talking about digital health. It was the main theme of our Policy Summit, which brought together operators and policymakers, and filled discussions from radiology to primary care to rehab. This week's infographic looks at the different patient pathways through remote consultations in operation across Europe.
The good news is it is now crystal clear what the winning business models are. The bad news is that no one has worked out how to negotiate the silos. Next week the global for-profit health care sector meets at HBI 2019 in London: What is the main theme?
Everybody in the lab sector likes to talk about how much it is consolidated across Europe. This week's infographic assesses that claim: it shows that over half the market is still owned by players with less than €100m revenues and only 15.5% by its top two players.
Ramsay Generale de Sante has revealed just €20m of synergies will be gained from its Capio deal, or around 1.8% of the deal value, highlighting the lower synergies accruable in the hospital sector compared with other sectors where the synergy-to-valuation ratio can be twice as high. Ramsay Generale de Sante’s second, successful offer for the […]
The world is facing a global healthcare workforce crisis. Technology is often cited as the universal panacea to this shortfall - but digital health companies are a long way away from being able to provide a solution - even if legislation allowed them to and the public was ready to fully embrace it.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
